Search research articles
Contact Us
Filters
Showing results (11-20 of 39) with videos related to
Page
of 4
Sort By:
Addiction (Abingdon, England)
|
September 18, 2025
Thresholds for adjunctive medication usage and probability of initiating injectable naltrexone
Kara E Rudolph, Shodai Inose, Nicholas T Williams, et al.
Drug and Alcohol Dependence
|
May 6, 2026
Beneficial effects of the rapid vs. standard procedure for injection naltrexone initiation operate through increased adjunctive medication use
Kara E Rudolph, Shodai Inose, Nicholas T Williams, et al.
Addiction (Abingdon, England)
|
August 5, 2024
Comparative effectiveness of extended-release naltrexone and sublingual buprenorphine for treatment of opioid use disorder among Medicaid patients
Rachael K Ross, Edward V Nunes, Mark Olfson, et al.
Journal of Dental Education
|
June 12, 2021
Predoctoral substance use disorders curricula: A survey analysis and experiential pedagogy
Folarin Odusola, Joshua Kaufman, Eva Turrigiano, et al.
Medrxiv : the Preprint Server for Health Sciences
|
February 12, 2024
Comparative effectiveness of extended release naltrexone and sublingual buprenorphine for treatment of opioid use disorder among Medicaid patients
Rachael K Ross, Edward V Nunes, Mark Olfson, et al.
Addiction Biology
|
December 8, 2021
Baseline- and treatment-associated pain in the X:BOT comparative effectiveness study of extended-release naltrexone versus buprenorphine-naloxone for OUD
An-Li Wang, Matisyahu Shulman, Tse-Hwei Choo, et al.
Journal of Addiction Medicine
|
December 2, 2017
Neurocognitive Profiling of Adult Treatment Seekers Enrolled in a Clinical Trial of a Web-delivered Intervention for Substance Use Disorders
Efrat Aharonovich, Aimee N C Campbell, Matisyahu Shulman, et al.
The American Journal on Addictions
|
June 8, 2025
Factors associated with receipt of second injection of naltrexone for opioid use disorder: Secondary analysis of 5 clinical trials
Matisyahu Shulman, Mei-Chen Hu, Maria A Sullivan, et al.
JAMA Network Open
|
October 4, 2024
Variation in Opioid Agonist Dosing in Clinical Trials by Race and Ethnicity
Rachael K Ross, Shodai Inose, Matisyahu Shulman, et al.
Drug and Alcohol Dependence
|
February 8, 2022
Patient characteristics associated with initiation of XR-naltrexone for opioid use disorder in clinical trials
Matisyahu Shulman, Mei-Chen Hu, Maria A Sullivan, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 39) with videos related to
Sort By:
Page
of 4
Addiction (Abingdon, England)
|
September 18, 2025
Thresholds for adjunctive medication usage and probability of initiating injectable naltrexone
Kara E Rudolph, Shodai Inose, Nicholas T Williams, et al.
Drug and Alcohol Dependence
|
May 6, 2026
Beneficial effects of the rapid vs. standard procedure for injection naltrexone initiation operate through increased adjunctive medication use
Kara E Rudolph, Shodai Inose, Nicholas T Williams, et al.
Addiction (Abingdon, England)
|
August 5, 2024
Comparative effectiveness of extended-release naltrexone and sublingual buprenorphine for treatment of opioid use disorder among Medicaid patients
Rachael K Ross, Edward V Nunes, Mark Olfson, et al.
Journal of Dental Education
|
June 12, 2021
Predoctoral substance use disorders curricula: A survey analysis and experiential pedagogy
Folarin Odusola, Joshua Kaufman, Eva Turrigiano, et al.
Medrxiv : the Preprint Server for Health Sciences
|
February 12, 2024
Comparative effectiveness of extended release naltrexone and sublingual buprenorphine for treatment of opioid use disorder among Medicaid patients
Rachael K Ross, Edward V Nunes, Mark Olfson, et al.
Addiction Biology
|
December 8, 2021
Baseline- and treatment-associated pain in the X:BOT comparative effectiveness study of extended-release naltrexone versus buprenorphine-naloxone for OUD
An-Li Wang, Matisyahu Shulman, Tse-Hwei Choo, et al.
Journal of Addiction Medicine
|
December 2, 2017
Neurocognitive Profiling of Adult Treatment Seekers Enrolled in a Clinical Trial of a Web-delivered Intervention for Substance Use Disorders
Efrat Aharonovich, Aimee N C Campbell, Matisyahu Shulman, et al.
The American Journal on Addictions
|
June 8, 2025
Factors associated with receipt of second injection of naltrexone for opioid use disorder: Secondary analysis of 5 clinical trials
Matisyahu Shulman, Mei-Chen Hu, Maria A Sullivan, et al.
JAMA Network Open
|
October 4, 2024
Variation in Opioid Agonist Dosing in Clinical Trials by Race and Ethnicity
Rachael K Ross, Shodai Inose, Matisyahu Shulman, et al.
Drug and Alcohol Dependence
|
February 8, 2022
Patient characteristics associated with initiation of XR-naltrexone for opioid use disorder in clinical trials
Matisyahu Shulman, Mei-Chen Hu, Maria A Sullivan, et al.
Page
of 4